# OnCo record gd2 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/gd2/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "gd2" ;
  schema:name "GD2 (disialoganglioside)"@en ;
  schema:alternateName "Disialoganglioside GD2"@en, "GD2 (B4GALNT1 product)" ;
  schema:description "GD2 is a sugar-fat molecule on the surface of neuroblastoma cells (and some other childhood and adult tumours) with almost none on normal tissue except nerves, which is why anti-GD2 drugs cause pain."@en ;
  schema:url <https://onco.cc/targets/gd2/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/GD2> ;
  owl:sameAs <http://www.wikidata.org/entity/Q4864602> ;
  schema:citation <https://en.wikipedia.org/wiki/GD2> ;
  onco:tag "antibody-target", "car-t-target" ;
  onco:targetClass "surface-antigen" ;
  onco:cancers <https://onco.cc/cancers/neuroblastoma/>, <https://onco.cc/cancers/sarcoma/>, <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:drugs <https://onco.cc/drugs/dinutuximab/>, <https://onco.cc/drugs/naxitamab/> ;
  onco:trials <https://onco.cc/trials/nct07744256/>, <https://onco.cc/trials/nct07480213/> .